Two isoforms of the GTPase-activating protein, regulator of G protein signaling 9 (RGS9), control such fundamental functions as vision and behavior. RGS9 -1 regulates phototransduction in rods and cones, and RGS9 -2 regulates dopamine and opioid signaling in the basal ganglia. To determine their functional differences in the same intact cell, we replaced RGS9 -1 with RGS9 -2 in mouse rods. Surprisingly, RGS9 -2 not only supported normal photoresponse recovery under moderate light conditions but also outperformed RGS9 -1 in bright light. This versatility of RGS9 -2 results from its ability to inactivate the G protein, transducin, regardless of its effector interactions, whereas RGS9 -1 prefers the G proteineffector complex. Such versatility makes RGS9 -2 an isoform advantageous for timely signal inactivation across a wide range of stimulus strengths and may explain its predominant representation throughout the nervous system. G proteins ͉ phototransduction ͉ RGS proteins P roteins of the regulators of G protein signaling (RGS) family are ubiquitous regulators of signal duration in many G protein pathways. Their RGS homology domain is directly responsible for accelerating the GTPase activity of G protein ␣-subunits, but most RGS proteins also contain additional domains, which vary greatly among the family members. Little is known about the functional roles of these non-catalytic domains, although they are thought to contribute to the specificity of RGS interactions (reviewed in 1, 2). RGS9 is one of the better-studied multidomain RGS proteins and exists in two splice isoforms (3-5), both of which form constitutive complexes with the type 5 G protein ␤ subunit, G␤5 (6-8). The difference between these isoforms resides in the structure of their C-termini: a short 18-aa sequence in RGS9-1 is replaced with 209 residues in RGS9-2 (Fig. 1A) .
P
roteins of the regulators of G protein signaling (RGS) family are ubiquitous regulators of signal duration in many G protein pathways. Their RGS homology domain is directly responsible for accelerating the GTPase activity of G protein ␣-subunits, but most RGS proteins also contain additional domains, which vary greatly among the family members. Little is known about the functional roles of these non-catalytic domains, although they are thought to contribute to the specificity of RGS interactions (reviewed in 1, 2). RGS9 is one of the better-studied multidomain RGS proteins and exists in two splice isoforms (3) (4) (5) , both of which form constitutive complexes with the type 5 G protein ␤ subunit, G␤5 (6) (7) (8) . The difference between these isoforms resides in the structure of their C-termini: a short 18-aa sequence in RGS9-1 is replaced with 209 residues in RGS9-2 (Fig. 1A) .
RGS9-1 is expressed exclusively in rod and cone photoreceptors where it sets the duration of electrical responses to light by accelerating the GTPase activity of transducin (3) . In mice, the lack of RGS9 causes a drastic delay in photoresponse recovery (9) , and its mutation in humans leads to difficulties in adjusting to bright light and seeing moving objects (10) . RGS9-2 is expressed predominantly in the striatum, where it controls reward behavior and movement coordination by regulating D2 dopamine and -opioid receptor signaling (11) (12) (13) (14) (15) . RGS9 knockout mice display augmented sensitivity to rewarding properties of morphine and cocaine (12, 13) and rapidly develop dyskinesias following administration of dopamine receptor antagonists (15) .
The physiological significance of having two RGS9 isoforms is unknown. High-affinity interaction of RGS9-1 with transducin requires that transducin first binds its effector, the ␥-subunit of cGMP phosphodiesterase (PDE␥) (16) . As a result, both RGS9-1 (9) and PDE␥ (17) are needed for timely GTP hydrolysis by transducin and normal recovery of the rod from light excitation. We hypothesized that the biological role for such a dual requirement is to ensure that the G protein would not inactivate before effector binding and therefore no signal would be lost before the effector is activated (17, 18) . In contrast, RGS9-2 does not require PDE␥ for high-affinity interaction with transducin but instead uses the PDE␥-like domain on its unique C terminus to increase the affinity between RGS9-2 and its target G proteins (19) . To investigate whether the unique properties of RGS9-1 are essential for attaining normal amplitude and time course of the photoresponse, we generated a transgenic mouse in which rods expressed RGS9-2 instead of RGS9-1 and studied the physiological consequences of this replacement.
Results
Characterization of the RGS9 -2 Transgenic Mouse. Transgenic mice expressing RGS9-2 instead of RGS9-1 in rods were generated by expressing the cDNA containing the coding sequence of the mouse RGS9-2 gene under the control of the rhodopsin promoter described in (20) (Fig. 1B ; see Experimental Procedures for details). Animals carrying the RGS9-2 transgene were crossbred to RGS9 knockout mice previously shown to have normal photoreceptor morphology and protein composition except for the lack of RGS9-1 and virtually complete loss of G␤5 (9) . Western blot analysis of retinal extracts indicated that two independent transgenic lines displayed similar robust expression of RGS9-2 (Fig. 1C) . The retinal morphology in these RGS9-2-expressing mice was normal (Fig. 1D) , with no signs of retinal degeneration. Consistently, the total amount of rhodopsin in their retinas measured at 3 months of age also was normal (466 Ϯ 57 pmol per retina vs. 470 Ϯ 110 pmol per retina in wild-type mice; SEM, n ϭ 4). The transgenic expression of RGS9-2 was accompanied by ϳ 70% restoration of the expression of its constitutive subunit, G␤5 (photoreceptorspecific long-splice variant; Fig. 2A ), indicating that both RGS9 isoforms can stabilize the G␤5 expression level in rods. Immunostaining of retina cross-sections with anti-RGS9-2 antibodies revealed that virtually all immunoreactivity was confined to the light-sensitive compartment of the rod cell, the outer segment (Fig.  1E) , replicating the pattern of RGS9-1 localization in wild-type rods (3).
Quantification of RGS9 -2⅐G␤5 Expression Level in the Retinas of
Transgenic Mice. Before assessing the expression level of RGS9-2 in transgenic rods, we re-examined the quantification of RGS9-1 in wild-type rods. Accurate determination of RGS9-1 levels in rods is very important because the time course of the rod's light response depends strongly on the RGS9 expression level (21) , but previous quantifications have yielded results varying from 1:1640 to 1:610 molar ratio with rhodopsin (3, 22) . The data from supporting information (SI) Fig. S1 offer a potential explanation for such variation. Mixing recombinant RGS9-1⅐G␤5 standards with even small amounts of rod outer-segment material obtained from the RGS9 knockout mouse significantly reduced its immunodetection efficiency, a phenomenon noted before for quantification of other proteins (23) . Therefore, to account for the microenvironment of the blotted proteins, the RGS9-1⅐G␤5 standards were mixed with rod outer-segment material from RGS9 knockout mice and analyzed alongside wild-type rod outer-segment samples matched by the amount of rhodopsin. These experiments explain the variation in previous estimates using different amounts of the outer-segment material and reveal that wild-type rods contain RGS9-1 in a 1:269 Ϯ 18 molar ratio with rhodopsin (SEM; n ϭ 8), which is about twofold more than the highest previous estimates and is comparable with the PDE amount in rods (22, 24) . We next assessed the expression level of RGS9-2⅐G␤5 in transgenic rods. In this case, we concentrated on quantifying the long-splice isoform of G␤5, which exists exclusively as a constitutive equimolar complex with RGS9 in photoreceptors (6, 9, 21, 25) . We chose G␤5 rather than RGS9-2 to avoid the inherent differences in antibody recognition by individual RGS9 isoforms. Furthermore, unlike G␤5, the two RGS9 isoforms run at different positions of the SDS gel, which makes their quantifications differentially sensitive to the protein microenvironment effects shown in Fig. S1 . The data in Fig. 2 demonstrate that transgenic retinas expressed 70% Ϯ 4% (n ϭ 3) of the G␤5, and thus ϳ 70% of the entire RGS9-2⅐G␤5 complex, of wild-type retinas. However, the data presented in the next section indicate that the expression of this RGS9-2⅐G␤5 varied significantly among individual rods.
Single-Cell Recordings Reveal Heterogeneous Expression of RGS9 -2 in
Transgenic Rods. To assess the ability of RGS9-2 to inactivate transducin in intact rods, we used suction electrodes to record their responses to brief flashes of varying strength (Fig. 3) . The light sensitivity of RGS9-2 rods was the same as that of the wild-type rods (Table 1) . Specifically, their responses to single photons reached the same peak amplitude at the same time, and the flash strength eliciting half-saturating response also was indistinguishable from that of wild-type rods. This finding indicates that the basic parameters of phototransduction activation in RGS9 -2 rods were normal. However, responses from RGS9-2 rods showed unusual variability in photoresponse recovery. Based on the exponential time constant of recovery, REC , the 45 individual rods analyzed in this study were separated Retinal morphology of 2-month-old mice containing RGS9 -2 transgene expressed on the RGS9 knockout background (RGS9 -2) and their wild-type littermates (RGS9 -1). Plastic-embedded 1-m-thick retina cross-sections were stained with toluidine blue. (E) Immunolocalization of RGS9 -2 in transgenic retinas. Frozen sections obtained from RGS9 -2 transgenic animals or their wild-type littermates were stained as described in Materials and Methods. DIC ϭ differential interference contrast image from the transgenic retina; GC ϭ ganglion cells; INL ϭ inner nuclear layer; IPL ϭ inner plexiform layer; IS ϭ photoreceptor inner segments; ONL ϭ outer nuclear layer; OPL ϭ outer plexiform layer; OS ϭ photoreceptor outer segments. into three distinct groups ( Fig. 3 and Table 1 ). One population (''wild-type-like''; REC between 0.1 and 0.3 s; n ϭ 28) exhibited dim flash responses that were indistinguishable from responses of wild-type rods. The second group of only two cells (''RGS9 knockout-like''; REC Ͼ 2 s) exhibited responses very similar to those of RGS9 knockout rods (9) . The third population (''intermediate''; n ϭ 15) exhibited intermediate dim flash response kinetics ( REC between 0.3 and 1.00 s). Because these three rod populations differed only in their response recovery, it is likely that they expressed variable amounts of RGS9-2, as occasionally observed in transgenic lines using this promoter (20) .
Cell-to-cell variability in RGS9-2 expression allows us to explain why the Western blot determination of G␤5 in Fig. 2B indicated that the amount of RGS9-2⅐G␤5 in whole retinas from the RGS9-2 mice was ϳ 70% of normal. Assuming that our sample size in the electrophysiological experiments reasonably reflected the total rod population of transgenic retinas and that wild-type-like rods contained normal RGS9 levels, knockoutlike rods contained none, and intermediate rods roughly half of the wild-type levels, the ''average'' RGS9-2⅐G␤5 expression level would fall at 79%, which is in good agreement with the ϳ 70% value determined by quantitative Western blotting.
The reason that the upper limit of the RGS9-2⅐G␤5 expression in transgenic rods matches the amount of RGS9-1⅐G␤5 in wild-type rods is because the amount of RGS9-1⅐G␤5 expression in rods is set ultimately by the amount of its membrane anchor, RGS9 anchor protein (R9AP) (21, 26) . The same rule should apply to both RGS9 isoforms because they share an identical R9AP-binding domain and both bind to R9AP with very high affinity (8, 27) . Therefore, in the rest of this study we concentrated on comparing the wild-type-like group of transgenic rods with wild-type rods. This comparison provided a unique opportunity to evaluate the functional properties of RGS9-1 and RGS9-2 in cells expressing them in equal amounts.
RGS9 -2 Rods Have Faster Bright-Flash Inactivation Kinetics than
Wild-Type Rods. At dim and moderate flash strengths, photoresponses from wild-type-like transgenic rods were identical to those from wild-type rods (Fig. 4 and Table 1 ). A close inspection of the average single-photon responses showed perfect agreement throughout the entire time course (Fig. 4 A, B) . The same was true for all responses to flashes producing up to 4,000 activated rhodopsin molecules (R*) (Fig. 4C ). This agreement demonstrates that under physiological conditions, RGS9-2 completely substitutes for RGS9-1 in transducin inactivation and does not interfere with PDE activation in this light regimen. Interestingly, these recordings did not show the approximately twofold inhibition of the RGS9-2 by PDE␥ identified in previous biochemical experiments (19) . Such inhibition would be expected to produce slower transducin inactivation and therefore slower response recovery. Potential explanations include the much higher concentrations of interacting proteins in intact rods and their persistent membrane localizations, neither of which can be achieved in vitro.
However, the most surprising result was that rods expressing RGS9-2 recovered significantly faster than wild-type rods in response to bright flashes (Fig. 5A) . The most common way of assessing recovery from bright saturating flashes is to measure the dominant time constant of recovery, D (Fig. 5B) , which is determined experimentally from the slope of the relation between response saturation time and the natural log of flash strength (the Pepperberg plot; see refs. 28, 29) . In normal mouse rods, D is ϳ 200 ms for responses to flashes up to a natural log of the flash strength of ϳ ln i ϭ 9 (ϳ4,000 R*/flash) and reflects the rate of transducin GTPase (21). For flashes activating over 4,000 R*, the relation rises more steeply (or ''breaks''), reflecting a significant slowing in the response recovery rate. Such slowing likely results from a depletion of one or more proteins responsible for normal deactivation of the phototransduction cascade (29) . Strikingly, RGS9-2 rods did not display a break in the 
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Number of cells (n) in each group are given in parentheses. For n Ͼ 10, values are mean Ϯ SEM. Id, Dark current as determined by the saturating response amplitude; I o -Flash strength that elicited a half-maximal response; D1, Dominant time constant of recovery for saturating flashes producing up to 4000 R*; D2, Dominant time constant of recovery for saturating flashes producing more than 4000 R*.
Pepperberg relation at any flash strength. The D of these rods was the same as that of wild-type rods before the breaking point and remained unchanged up to the brightest flashes that could be delivered by our source (producing over 50,000 R*). Thus RGS9-2 mediates timely transducin inactivation over a broader range of flash strength than RGS9-1.
The ability of transgenic rods to recover more rapidly from brighter flashes is likely to arise from the major difference between RGS9 isoforms revealed in biochemical experiments: RGS9-1 requires PDE␥ to inactivate transducin rapidly, and RGS9-2 does not. Binding to PDE␥ increases transducin's affinity for RGS9-1 by more than 20-fold (16), whereas the PDE␥-like domain of RGS9-2 relieves this requirement (19) . Because rods contain ϳ 10-fold more transducin than PDE (reviewed in 30), bright light can cause transducin activation in excess of PDE. In wild-type rods, this excess transducin is expected to be inactivated by RGS9-1 more slowly than the PDE-bound transducin, and this difference presumably causes the break in the Pepperberg relation. In contrast, RGS9-2 inactivates this excess transducin very efficiently, making transgenic rods able to recover more rapidly from brighter flashes and preventing the break in the Pepperberg relation (Fig. 5B) .
Discussion
The central observation of this study is that rods expressing the brain-specific splice isoform of RGS9, RGS9-2, achieved efficient photoresponse recovery over a broader range of light intensities than normal rods expressing the photoreceptorspecific RGS9-1. This result is not intuitive and inevitably raises the question why rods employ an apparently ''inferior'' isoform of this protein. Although we realize that in biology the question ''why'' is not nearly as legitimate as the question ''how,'' searching for the answer provides an opportunity to revisit the functional and evolutionary specializations of the visual transduction pathway.
Why do Photoreceptors Use RGS9 -1? Effective single-photon detection by rods requires that the signal from the activated rhodopsin to PDE be relayed with high efficiency. In our previous study (17) , we demonstrated that PDE␥ is required for timely GTP hydrolysis by RGS9-1 in vivo and proposed that this requirement contributes to this coupling efficiency by preventing transducin inactivation before binding PDE (see also 18). However, we now demonstrate that there is no detectable difference in the kinetics of the photoresponse rising phases in rods expressing RGS9-1 or RGS9-2, despite the ability of RGS9-2 to inactivate free transducin efficiently. Although this result may seem surprising initially, it simply reveals that in the intact cell, transducin interacts with PDE much more rapidly than with either RGS9 isoform, even though PDE and RGS9 isoforms are expressed in comparable amounts. Indeed, transducin is known to bind and activate PDE within a few milliseconds (31) , whereas the average time for either RGS9 isoform to inactivate transducin is ϳ 100 times longer (the value of the D ; Fig. 5 and Table  1 ). Therefore, the coupling efficiency between transducin and PDE is so high that specific binding properties of a given RGS9 isoform are insignificant for preserving signal amplification.
On the other hand, although we typically consider ''faster'' to be better, there are some practical considerations that suggest that the slower transducin inactivation in bright light may be desirable for rod function. In rods, massive light-driven translocation of transducin from the outer segment to other subcellular compartments (reviewed in 32, 33) can contribute to light adaptation (34) and may be neuroprotective by reducing energy metabolism through the mechanism of decreasing the amount of transducin available for activation (35, 36) . Because the extent of translocation is proportional to the time that transducin is active (37, 38) , the inability of RGS9-1 to inactivate efficiently the transducin produced in excess of PDE␥ may benefit this process.
Another idea is that the presence of RGS9-1 in photoreceptors reflects the evolutionary origin of the phototransduction cascade. RGS proteins exist in all eukaryotic organisms, whereas no PDE␥ genes have yet been discovered in species more ancient than lamprey (39) . Thus, PDE␥ emerged in evolution during the time when high-affinity transducin interactions with RGS proteins already existed. Accordingly, we speculate that the PDE␥ prototype may not have had such a high affinity for transducin as the modern-day PDE␥ and that the formation of the entire transducin-PDE␥-RGS9 molecular module was possible because of the selection for an RGS protein isoform that would not inactivate transducin before it binds and activates PDE. The similarities in sequence and function between the C terminus of RGS9-2 and PDE␥ (19) also raise the question of whether one evolved from the other. Consistently, the RGS9 and PDE␥ genes are located on the same region of chromosome 17 (within loci 17q24-17q25 in the human genome). However, because of the current gaps in the genome sequences of the lamprey and its immediate predecessor, the hagfish (see 40 for a review on evolution of the eye), we cannot determine which of these alternatives is more probable.
PDE Rate-Limits Rod Response Recovery to Bright Flashes. Our discovery that RGS9-1 and RGS9-2 differ in their ability to mediate photoresponse recovery in bright light also has revealed the mechanism limiting rod temporal resolution under those conditions. The temporal resolution of vision depends on timely recovery of the light-sensitive current in photoreceptors. In normal mammalian rods, flashes that activate from 1 to 4,000 R* produce responses that recover at an invariant rate. On the molecular level, this rate is determined by the inactivation of the complex between transducin and PDE caused by the RGS9-1-stimulated transducin GTPase activity (21) . However, for flashes activating more than 4,000 R* the time constant of recovery slows, indicating that the biochemical reaction that rate-limits recovery has changed. This slowing (at the break of the Pepperberg relation) was proposed to arise from either slowed rhodopsin inactivation or slowed GTP hydrolysis (29) , but neither of these putative explanations had been tested experimentally. Here, we demonstrate that transgenic replacement of RGS9-1 with RGS9-2 abolishes this slowing, so that photoresponse recovery rate remains invariant from 1 to at least 50,000 R*. Therefore response recovery to flashes exciting 4,000-50,000 R* normally is limited by the inactivation of transducin produced in excess of PDE␥, which is not a good substrate for RGS9-1. Thus, normally, it is the amount of PDE␥, not the slowing of rhodopsin inactivation, that sets the dominant time constant for recovery of responses to very bright flashes.
The conclusion that in normal rods the amount of activated transducin exceeds the amount of available PDE after a flash producing more than 4,000 R* is generally consistent with available biochemical estimates of phototransduction activation (see ref. 41 for a detailed review). Each of the 4,000 R* is predicted to activate up to ϳ 400 transducin molecules per second (the highest rate of ϳ 150/s measured in rod outersegment suspensions at 22°C (42) projected to the rate at 37°C using the relation from (43) ). The average lifetime of each R* can be as long as the value of the nondominant time constant of the phototransduction cascade inactivation, ϳ 0.08 s (21) . Thus the total number of transducin molecules activated by 4,000 R* is ϳ 4,000 ϫ 400 ϫ 0.08 Ϸ130,000. This number is comparable to the total number of PDE molecules in a rod, calculated as follows. The typical length of a rod outer segment in our recordings was ϳ 20 m and contained ϳ 5 ϫ10 7 rhodopsin molecules (44) . Based on the rhodopsin to PDE ratio of ϳ 300:1 (24) , there are ϳ 170,000 PDE molecules per rod, a number reasonably close to the estimated ϳ 130,000 activated transducins, particularly given the major differences in experimental conditions under which individual numbers used in these calculations were obtained.
In summary, comparison of RGS9 -1 and RGS9 -2 in controlling the light responses of rods has revealed that RGS9 -2 not only completely substituted for RGS9 -1 under dim to moderate light intensities but also outperformed RGS9 -1 in bright light. Although we argue that the presence of RGS9 -1 in photoreceptors may ref lect the evolutionary history of its cellular function, RGS9 -2 seems to be a more versatile isoform of this protein that can function efficiently anywhere rapid inactivation of its G protein target(s) is needed. Such versatility may explain its wider expression pattern throughout the nervous system.
Materials and Methods
DNA Constructs, Rod Outer Segments, Recombinant Proteins, and Antibodies. Generation of expression constructs for RGS9 -1 and G␤5 (long-splice variant) was described in (19) . The recombinant RGS9⅐G␤5 complexes were expressed in the insect Sf9/baculovirus system, purified by Ni-NTA chromatography, and their concentrations were measured by UV spectroscopy as in (45) . Osmotically intact mouse rod outer segments were prepared as in (17) . Rhodopsin concentration in all photoreceptor membrane and retina lysate preparations was determined spectrophotometrically using 500 ϭ 40,000. Transducin was purified from frozen bovine retinas (46) , and its concentration was determined based on the maximum amount of rhodopsin-catalyzed GTP␥S binding (47) . Western blot and immunohistochemical detection of RGS9 -2 was performed using sheep antibodies against its C-terminal epitope (8) . G␤5 was detected using the sheep antibody against the N-terminal epitope of its long-splice isoform (6). RGS9 -1 was detected using the sheep antibody against the RGS9 -1 fragment called ''RGS9c'' (6).
Generation of RGS9 -2 Transgenic Mouse. The DNA region encoding mouse RGS9 -2 was subcloned into pBamH4.4, a rod-specific mammalian expression vector. In the resulting plasmid the ORF of RGS9 -2 was located under the control of a 4.4-kb mouse opsin promoter region and supplied with the polyadenylation signal of the mouse protamine gene (20) . The construct was injected into the pronuclei of oocytes from superovulated females of BDF1 strain (F1 of C57/Bl6 ϫ DBA/2 from Charles River Laboratories). The transgene integration was determined by PCR analysis of tail DNA. To establish the transgenic line, where RGS9 -2 is expressed on a RGS9 knockout background, founders were crossed with RGS9 knockout mice for two generations (9) .
Immunohistochemistry. For immunohistochemical detection of RGS9 -2 in retina sections, eyes were fixed for 4 h with paraformaldehyde (4% in PBS) at 4°C, cryoprotected with 30% sucrose in PBS at 4°C, and mounted in embedding medium (Tissue-Tek OCT Compound, Sakura Finetek). Frozen sections were obtained, rehydrated, blocked with PBT1 (PBS, 0.1% Triton-100, 1% BSA (wt/vol), 5% heat-inactivated goat serum) for 1 h, incubated with the same primary antibody as used for Western blotting in PBT1 overnight at 4°C, washed four times with PBT2 (PBS, 0.1% Triton-100, 1% BSA), and incubated with Alexa 488-conjugated secondary antibodies in PBT2 for 2 h. After being washed twice with PBT2 for 5 min and with PBS for 5 min, sections were mounted in anti-fading media (Pierce) and analyzed using a laser-scanning confocal microscope.
Single-Cell Electrophysiology. Suction electrode recordings from dark-adapted rods were conducted as described in (25) . The average response to a large number (Ͼ30) of flashes was considered to be in the linear range if its mean amplitude was less than 20% of the maximal response amplitude. These dim-flash responses were used to estimate the form of the single-photon response using the ''variance to mean'' method described in (48) . Integration time was used as a measure of the duration of the incremental flash response and is defined as the time integral of the average linear response divided by its peak amplitude (49) . The time that a bright-flash response remained in
